|
ATE101203T1
(de)
|
1985-01-28 |
1994-02-15 |
Xoma Corp |
Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
IN165717B
(cg-RX-API-DMAC7.html)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US6004781A
(en)
|
1988-01-22 |
1999-12-21 |
The General Hospital Corporation |
Nucleic acid encoding Ig-CD4 fusion proteins
|
|
IL86278A
(en)
|
1988-05-04 |
2003-06-24 |
Yeda Res & Dev |
Endowing cells with antibody specificity using chimeric t cell receptor
|
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US6406697B1
(en)
|
1989-02-23 |
2002-06-18 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5216132A
(en)
|
1990-01-12 |
1993-06-01 |
Protein Design Labs, Inc. |
Soluble t-cell antigen receptor chimeric antigens
|
|
US20020004052A1
(en)
|
1990-05-08 |
2002-01-10 |
David Berd |
Composition comprising a tumor cell extract and method of using the composition
|
|
US5914109A
(en)
|
1990-06-15 |
1999-06-22 |
New York University |
Heterohybridomas producing human monoclonal antibodies to HIV-1
|
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
US6407221B1
(en)
|
1990-12-14 |
2002-06-18 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
US20020111474A1
(en)
|
1990-12-14 |
2002-08-15 |
Capon Daniel J. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
AU643109B2
(en)
|
1990-12-14 |
1993-11-04 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
IL101147A
(en)
|
1991-03-07 |
2004-06-20 |
Gen Hospital Corp |
Redirection of cellular immunity by receptor chimeras
|
|
US6753162B1
(en)
|
1991-03-07 |
2004-06-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
US7049136B2
(en)
|
1991-03-07 |
2006-05-23 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
JPH06505396A
(ja)
|
1991-03-08 |
1994-06-23 |
サイトメッド,インコーポレイテッド |
可溶性cd28タンパク質およびそれを用いる治療方法
|
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
|
CA2121487A1
(en)
|
1991-10-21 |
1993-04-29 |
Stephen A. Sherwin |
Combined cellular and immunosuppresive therapies
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
US5372930A
(en)
|
1992-09-16 |
1994-12-13 |
The United States Of America As Represented By The Secretary Of The Navy |
Sensor for ultra-low concentration molecular recognition
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
WO1994009820A1
(en)
|
1992-11-05 |
1994-05-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US5861156A
(en)
|
1993-01-08 |
1999-01-19 |
Creative Biomolecules |
Methods of delivering agents to target cells
|
|
EP0693084A4
(en)
|
1993-04-06 |
1999-06-02 |
Hutchinson Fred Cancer Res |
CHIMERAL CYTOKINE RECEPTORS IN LYMPHOCYTE
|
|
US6051427A
(en)
|
1993-06-11 |
2000-04-18 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
|
US5834256A
(en)
|
1993-06-11 |
1998-11-10 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
|
US5525503A
(en)
|
1993-09-28 |
1996-06-11 |
Dana-Farber Cancer Institute, Inc. |
Signal transduction via CD28
|
|
US5935818A
(en)
|
1995-02-24 |
1999-08-10 |
Sloan-Kettering Institute For Cancer Research |
Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
|
|
NZ285395A
(en)
|
1994-05-02 |
1998-10-28 |
Novartis Ag |
Chimeric antibody, cancer treatment
|
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
|
US7354587B1
(en)
|
1994-07-06 |
2008-04-08 |
Immunomedics, Inc. |
Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
|
|
CA2204183A1
(en)
|
1994-11-01 |
1996-05-09 |
Andrew Lawrence Feldhaus |
Chimeric receptors for the generation of selectively-activatable th-independent cytotoxic t cells
|
|
US5741899A
(en)
|
1995-02-02 |
1998-04-21 |
Cell Genesys, Inc. |
Chimeric receptors comprising janus kinase for regulating cellular pro liferation
|
|
US5712149A
(en)
|
1995-02-03 |
1998-01-27 |
Cell Genesys, Inc. |
Chimeric receptor molecules for delivery of co-stimulatory signals
|
|
US6103521A
(en)
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
|
JP2001526522A
(ja)
|
1995-02-24 |
2001-12-18 |
スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
前立腺特異的膜抗原およびその使用
|
|
US5830755A
(en)
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
GB9526131D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Recombinant chimeric receptors
|
|
WO1997034634A1
(en)
|
1996-03-20 |
1997-09-25 |
Sloan-Kettering Institute For Cancer Research |
Single chain fv constructs of anti-ganglioside gd2 antibodies
|
|
US6261787B1
(en)
|
1996-06-03 |
2001-07-17 |
Case Western Reserve University |
Bifunctional molecules for delivery of therapeutics
|
|
US5969102A
(en)
|
1997-03-03 |
1999-10-19 |
St. Jude Children's Research Hospital |
Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
|
|
US20020018783A1
(en)
|
1997-03-20 |
2002-02-14 |
Michel Sadelain |
Fusion proteins of a single chain antibody and cd28 and uses thereof
|
|
AU8142598A
(en)
|
1997-06-11 |
1998-12-30 |
New York University |
Prenylcysteine carboxyl methyltransferase, dna encoding same, and a method of screening for inhibitors thereof
|
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US20090011984A1
(en)
|
1998-02-23 |
2009-01-08 |
Seppo Yla-Herttuala |
Biotin-binding receptor molecules
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
JP2002524081A
(ja)
|
1998-09-04 |
2002-08-06 |
スローン − ケッタリング インスティチュート フォー キャンサー リサーチ |
前立腺−特異的膜抗原に特異的な融合受容体およびその使用
|
|
US6410319B1
(en)
|
1998-10-20 |
2002-06-25 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
US6534633B1
(en)
|
1998-10-21 |
2003-03-18 |
Altor Bioscience Corporation |
Polyspecific binding molecules and uses thereof
|
|
US7217421B1
(en)
|
1998-11-03 |
2007-05-15 |
Cell Genesys, Inc. |
Cancer-associated antigens and methods of their identification and use
|
|
CA2362995A1
(en)
|
1999-03-01 |
2000-09-08 |
Cell Genesys, Inc. |
Anti-neoplastic compositions and uses thereof
|
|
EP1171596A1
(en)
|
1999-04-16 |
2002-01-16 |
Celltech Therapeutics Limited |
Synthetic transmembrane components
|
|
US6699972B1
(en)
|
1999-06-25 |
2004-03-02 |
Academia Sinica |
Chimeric protein and method of controlling tumor growth using the protein
|
|
US7569663B2
(en)
|
2000-01-03 |
2009-08-04 |
Mark L. Tykocinski |
Chimeric proteins and methods for using the same
|
|
AU2001236967A1
(en)
|
2000-02-14 |
2001-08-27 |
The Regents Of The University Of California |
Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
|
|
US6770749B2
(en)
|
2000-02-22 |
2004-08-03 |
City Of Hope |
P53-specific T cell receptor for adoptive immunotherapy
|
|
CN102805868A
(zh)
|
2000-03-31 |
2012-12-05 |
普渡研究基金会 |
用配体-免疫原缀合物治疗的方法
|
|
WO2001091625A2
(en)
|
2000-04-21 |
2001-12-06 |
Rutgers, The State University Of New Jersey |
Methods and compositions for the diagnosis of schizophrenia
|
|
US6524572B1
(en)
|
2000-06-26 |
2003-02-25 |
Rainbow Therapeutic Company |
Targeting recombinant virus with a bispecific fusion protein ligand in coupling with an antibody to cells for gene therapy
|
|
ES2304398T3
(es)
|
2000-07-31 |
2008-10-16 |
Green Peptide Co., Ltd. |
Antigeno de tumores.
|
|
US7666424B2
(en)
|
2001-10-17 |
2010-02-23 |
Sloan-Kettering Institute For Cancer Research |
Methods of preparing and using single chain anti-tumor antibodies
|
|
JP5312721B2
(ja)
|
2000-11-07 |
2013-10-09 |
シティ・オブ・ホープ |
Cd19特異的再指向免疫細胞
|
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
EP1392818A4
(en)
|
2001-04-30 |
2005-01-05 |
Hope City |
FOR THE TREATMENT OF CANCER DISEASES IN HUMAN CERTAIN IMMUNE RECEPTOR
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
EP1569514A4
(en)
|
2002-08-16 |
2007-10-31 |
|
SPECIFIC ANTIGEN OF TUMORS, PEPTIDES ASSOCIATED THERETO AND USE THEREOF AS IMMUNOMINAL VACCINES
|
|
AU2003265866A1
(en)
|
2002-09-03 |
2004-03-29 |
Vit Lauermann |
Targeted release
|
|
DE10244457A1
(de)
|
2002-09-24 |
2004-04-01 |
Johannes-Gutenberg-Universität Mainz |
Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
|
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
|
US20060018878A1
(en)
|
2003-03-11 |
2006-01-26 |
City Of Hope |
Dual antigen specific T cells with trafficking ability
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
US20050113564A1
(en)
|
2003-11-05 |
2005-05-26 |
St. Jude Children's Research Hospital |
Chimeric receptors with 4-1BB stimulatory signaling domain
|
|
US20130266551A1
(en)
|
2003-11-05 |
2013-10-10 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptors with 4-1bb stimulatory signaling domain
|
|
US8652484B2
(en)
|
2004-02-13 |
2014-02-18 |
Immunomedics, Inc. |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
|
|
US7196062B2
(en)
|
2004-02-18 |
2007-03-27 |
Wisconsin Alumni Research Foundation |
Method for treating glaucoma
|
|
EP2044961B1
(en)
|
2004-03-02 |
2013-07-17 |
Cellectar, Inc. |
Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
|
|
EP2112162B1
(en)
|
2004-07-10 |
2015-01-14 |
Fox Chase Cancer Center |
Genetically modified human natural killer cell lines
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
|
US7994298B2
(en)
|
2004-09-24 |
2011-08-09 |
Trustees Of Dartmouth College |
Chimeric NK receptor and methods for treating cancer
|
|
ATE549398T1
(de)
|
2004-10-08 |
2012-03-15 |
Us Gov Health & Human Serv |
Adoptive immuntherapie mit erhöhter t-lymphozyten-lebensdauer
|
|
AU2005335714B2
(en)
|
2004-11-10 |
2012-07-26 |
Macrogenics, Inc. |
Engineering Fc antibody regions to confer effector function
|
|
WO2007044033A2
(en)
|
2004-12-07 |
2007-04-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
|
|
US20070036773A1
(en)
|
2005-08-09 |
2007-02-15 |
City Of Hope |
Generation and application of universal T cells for B-ALL
|
|
CA2632094C
(en)
|
2005-12-02 |
2015-01-27 |
Wayne A. Marasco |
Carbonic anhydrase ix (g250) antibodies and methods of use thereof
|
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
|
CN105837690A
(zh)
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
US20100105136A1
(en)
|
2006-10-09 |
2010-04-29 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
|
US9334330B2
(en)
|
2006-10-10 |
2016-05-10 |
Universite De Nantes |
Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers
|
|
US8685752B2
(en)
|
2006-11-03 |
2014-04-01 |
Purdue Research Foundation |
Ex vivo flow cytometry method and device
|
|
WO2008060510A2
(en)
|
2006-11-13 |
2008-05-22 |
Sangamo Biosciences, Inc. |
Zinc finger nuclease for targeting the human glucocorticoid receptor locus
|
|
US20080131415A1
(en)
|
2006-11-30 |
2008-06-05 |
Riddell Stanley R |
Adoptive transfer of cd8 + t cell clones derived from central memory cells
|
|
US8748405B2
(en)
|
2007-01-26 |
2014-06-10 |
City Of Hope |
Methods and compositions for the treatment of cancer or other diseases
|
|
ATE504647T1
(de)
|
2007-01-30 |
2011-04-15 |
Forerunner Pharma Res Co Ltd |
Chimärer fc gamma rezeptor und verfahren zur bestimmung von adcc-aktivität unter verwendung des rezeptors
|
|
ES2595307T3
(es)
|
2007-01-31 |
2016-12-29 |
Yeda Research And Development Company Limited |
Células T reguladoras redirigidas, modificadas genéticamente y su uso en la supresión de enfermedades autoinmunes e inflamatorias
|
|
WO2008097926A2
(en)
|
2007-02-02 |
2008-08-14 |
Yale University |
Transient transfection with rna
|
|
US8865169B2
(en)
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
|
PT2856876T
(pt)
|
2007-03-30 |
2018-03-28 |
Memorial Sloan Kettering Cancer Center |
Expressão constitutiva de ligantes co-estimulatórios em linfócitos t adotivamente transferidos
|
|
JPWO2009020094A1
(ja)
|
2007-08-09 |
2010-11-04 |
第一三共株式会社 |
疎水性分子で修飾した抗体
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
US20110070191A1
(en)
|
2008-03-19 |
2011-03-24 |
Wong Hing C |
T cell receptor fusions and conjugates and methods of use there of
|
|
US8450112B2
(en)
|
2008-04-09 |
2013-05-28 |
Maxcyte, Inc. |
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
|
RS51975B
(sr)
|
2008-04-11 |
2012-02-29 |
Emergent Product Development Seattle Llc. |
Cd37 imunoterapeutski proizvod i njegova kombinacija sa bifunkcionalnim hemoterapeutskim sredstvom
|
|
US20090324630A1
(en)
|
2008-04-21 |
2009-12-31 |
Jensen Michael C |
Fusion multiviral chimeric antigen
|
|
JP2012501180A
(ja)
|
2008-08-26 |
2012-01-19 |
シティ・オブ・ホープ |
T細胞の抗腫瘍エフェクター機能増進のための方法および組成物
|
|
PL2349274T3
(pl)
|
2008-09-17 |
2025-09-22 |
Endocyte, Inc. |
Koniugaty antyfolianów wiążące się z receptorem folianów
|
|
GB2483810B
(en)
|
2008-11-07 |
2012-09-05 |
Sequenta Inc |
Methods for correlating clonotypes with diseases in a population
|
|
EP3936122A1
(en)
|
2008-11-24 |
2022-01-12 |
Massachusetts Institute Of Technology |
Methods and compositions for localized agent delivery
|
|
WO2010132532A1
(en)
|
2009-05-15 |
2010-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
US20100322909A1
(en)
|
2009-06-17 |
2010-12-23 |
The University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Th1-associated micrornas and their use for tumor immunotherapy
|
|
US8465743B2
(en)
|
2009-10-01 |
2013-06-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
US9211321B2
(en)
|
2009-10-27 |
2015-12-15 |
Immunicum Ab |
Method for proliferation of antigen-specific T cells
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
US9181527B2
(en)
|
2009-10-29 |
2015-11-10 |
The Trustees Of Dartmouth College |
T cell receptor-deficient T cell compositions
|
|
EP4049674A1
(en)
|
2009-11-03 |
2022-08-31 |
City of Hope |
Truncated epidermal growth factor receptor (egfrt) for transduced t cell selection
|
|
CN102762719A
(zh)
|
2009-12-08 |
2012-10-31 |
威尔森沃尔夫制造公司 |
用于过继细胞疗法的细胞培养的改进方法
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
CN102947453A
(zh)
|
2010-01-28 |
2013-02-27 |
费城儿童医院 |
用于病毒载体纯化的可扩缩生产平台和用于基因治疗中的如此纯化的病毒载体
|
|
EP2531216B1
(en)
|
2010-02-04 |
2019-03-27 |
The Trustees Of The University Of Pennsylvania |
Icos critically regulates the expansion and function of inflammatory human th17 cells
|
|
JP6034696B2
(ja)
|
2010-02-12 |
2016-11-30 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
ポリペプチド発現細胞の同定及び単離の方法
|
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
|
ES2620259T3
(es)
|
2010-04-14 |
2017-06-28 |
Roger Williams Medical Center |
Métodos y composiciones para tratar VIH
|
|
ES2686424T5
(es)
|
2010-05-04 |
2023-03-27 |
Yeda Res & Dev |
Inmunoterapia con células alogénicas redireccionadas
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
WO2011159847A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
|
|
WO2012012695A2
(en)
|
2010-07-23 |
2012-01-26 |
Fred Hutchinson Cancer Research Center |
A method for the treatment of obesity
|
|
DE102010036122A1
(de)
|
2010-09-01 |
2012-03-01 |
Nora Systems Gmbh |
Bodenbelag
|
|
WO2012033885A1
(en)
|
2010-09-08 |
2012-03-15 |
Baylor College Of Medicine |
Immunotherapy of cancer using genetically engineered gd2-specific t cells
|
|
PT3012268T
(pt)
|
2010-09-08 |
2018-01-31 |
Chemotherapeutisches Forschungsinstitut Georg Speyer Haus |
Recetores de antigénio quimérico com uma região de charneira otimizada
|
|
EP2614151B1
(en)
|
2010-09-08 |
2019-07-24 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
|
ES2876176T3
(es)
|
2010-09-21 |
2021-11-12 |
The Us Secretary Department Of Health And Human Services Office Of Technology Transfer National Inst |
Receptores de células T anti-SSX-2 y materiales relacionados y métodos de uso
|
|
CN103154257A
(zh)
|
2010-09-26 |
2013-06-12 |
大玉企业有限公司 |
重组大分子生成方法
|
|
US9845362B2
(en)
|
2010-10-08 |
2017-12-19 |
The University Of North Carolina At Charlotte |
Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
|
|
WO2012054825A1
(en)
|
2010-10-22 |
2012-04-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mage-a3 t cell receptors and related materials and methods of use
|
|
WO2012076059A1
(en)
|
2010-12-09 |
2012-06-14 |
Stichting Het Nederlands Kanker Instituut |
Immune restricted peptides with increased efficacy
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
EP2651442B1
(en)
|
2010-12-14 |
2020-04-22 |
University of Maryland, Baltimore |
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
|
|
US9402865B2
(en)
|
2011-01-18 |
2016-08-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating cancer
|
|
US9040669B2
(en)
|
2011-02-11 |
2015-05-26 |
Memorial Sloan Kettering Cancer Center |
HLA-restricted, peptide-specific antigen binding proteins
|
|
BR112013024395B1
(pt)
|
2011-03-23 |
2021-10-26 |
Fred Hutchinson Cancer Research Center |
Composições adotivas de imunoterapia celular e método para fabricação da dita composição
|
|
EP2502934B1
(en)
|
2011-03-24 |
2018-01-17 |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
|
|
EP3323833B1
(en)
|
2011-04-01 |
2019-12-04 |
Memorial Sloan-Kettering Cancer Center |
T cell receptor-like bispecific antibodies specific for a wt1 peptide presented by hla-a2
|
|
PT3459560T
(pt)
|
2011-04-08 |
2021-05-24 |
Us Health |
Recetores de antigénio quimérico variante iii de recetor de fator de crescimento antiepidérmico e utilização dos mesmos para o tratamento de cancro
|
|
KR102028340B1
(ko)
|
2011-04-13 |
2019-10-04 |
이뮤니쿰 에이비 |
항원-특이적 t 세포의 증식 방법
|
|
US9492529B2
(en)
|
2011-04-13 |
2016-11-15 |
Immunicum Ab |
Method for priming of T cells
|
|
CN105968209B
(zh)
|
2011-04-19 |
2021-08-03 |
美国政府(由卫生和人类服务部的部长所代表) |
对磷脂酰肌醇蛋白聚糖3特异的人单克隆抗体及其用途
|
|
GB201108236D0
(en)
|
2011-05-17 |
2011-06-29 |
Ucl Business Plc |
Method
|
|
EA201490364A1
(ru)
|
2011-07-29 |
2014-08-29 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Костимулирующие рецепторы-переключатели
|
|
MX356947B
(es)
|
2011-08-23 |
2018-06-20 |
Roche Glycart Ag |
Anticuerpos bioespecíficos específicos para antígenos que activan células t y un antígeno tumoral y métodos de uso.
|
|
US9833476B2
(en)
|
2011-08-31 |
2017-12-05 |
The Trustees Of Dartmouth College |
NKP30 receptor targeted therapeutics
|
|
EP3766896B1
(en)
|
2011-09-15 |
2025-11-05 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
|
|
WO2013040371A2
(en)
|
2011-09-16 |
2013-03-21 |
Baylor College Of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
AU2012308205A1
(en)
|
2011-09-16 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
RNA engineered T cells for the treatment of cancer
|
|
US9708384B2
(en)
|
2011-09-22 |
2017-07-18 |
The Trustees Of The University Of Pennsylvania |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
|
|
KR101956751B1
(ko)
|
2011-10-07 |
2019-03-11 |
고쿠리츠다이가쿠호진 미에다이가쿠 |
키메라 항원 수용체
|
|
RU2644243C2
(ru)
|
2011-10-20 |
2018-02-08 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы к cd22
|
|
US9688740B2
(en)
|
2011-10-26 |
2017-06-27 |
National Cancer Center |
Mutant CTLA4 gene transfected T cell and composition including same for anticancer immunotherapy
|
|
US9272002B2
(en)
|
2011-10-28 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
|
WO2013063019A1
(en)
|
2011-10-28 |
2013-05-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells
|
|
WO2013067492A1
(en)
|
2011-11-03 |
2013-05-10 |
The Trustees Of The University Of Pennsylvania |
Isolated b7-h4 specific compositions and methods of use thereof
|
|
US20140322216A1
(en)
|
2011-11-08 |
2014-10-30 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
EP2776451B1
(en)
|
2011-11-11 |
2018-07-18 |
Fred Hutchinson Cancer Research Center |
Cyclin a1-targeted t-cell immunotherapy for cancer
|
|
CN104080462B
(zh)
|
2011-12-16 |
2019-08-09 |
塔尔盖特基因生物技术有限公司 |
用于修饰预定的靶核酸序列的组合物和方法
|
|
CA3111357A1
(en)
|
2011-12-23 |
2013-06-27 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
JP2015506372A
(ja)
|
2012-01-27 |
2015-03-02 |
グリックニック インコーポレイテッド |
IgG2ヒンジドメインを含む融合タンパク質
|
|
EP3594245A1
(en)
|
2012-02-13 |
2020-01-15 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
SG11201404769UA
(en)
|
2012-02-22 |
2014-11-27 |
Univ Pennsylvania |
Use of icos-based cars to enhance antitumor activity and car persistence
|
|
EP2817331B1
(en)
|
2012-02-22 |
2023-08-30 |
The Trustees of the University of Pennsylvania |
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
|
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
|
CA2868121C
(en)
|
2012-03-23 |
2021-06-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
EP2836239A1
(en)
|
2012-04-11 |
2015-02-18 |
The United States of America, as Represented By the Secretary, Department of Health and Human Services |
Chimeric antigen receptors targeting b-cell maturation antigen
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
CN104395462B
(zh)
|
2012-05-03 |
2017-09-26 |
弗雷德哈钦森癌症研究中心 |
增强亲和力的t细胞受体及其制备方法
|
|
EP3505537A1
(en)
|
2012-05-07 |
2019-07-03 |
Trustees of Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
|
HK1209100A1
(en)
|
2012-05-22 |
2016-03-24 |
基因泰克有限公司 |
N-substituted benzamides and their use in the treatment of pain
|
|
EP2852613B1
(en)
|
2012-05-22 |
2019-01-23 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Murine anti-ny-eso-1 t cell receptors
|
|
EP2855666B1
(en)
|
2012-05-25 |
2019-12-04 |
Cellectis |
Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells
|
|
SG11201407972RA
(en)
|
2012-06-01 |
2015-01-29 |
Us Health |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
|
EP2878670B1
(en)
|
2012-06-08 |
2019-08-07 |
Kinki University |
Antibody against transporter and use thereof
|
|
JP5863585B2
(ja)
|
2012-07-11 |
2016-02-16 |
三菱電機株式会社 |
大信号等価回路モデルを用いたトランジスタ特性計算装置
|
|
KR20150029714A
(ko)
|
2012-07-13 |
2015-03-18 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
이중특이적 항체의 공-도입에 의한 car 세포의 활성 증강
|
|
AU2013289979A1
(en)
|
2012-07-13 |
2015-01-22 |
The Trustees Of The University Of Pennsylvania |
Methods of assessing the suitability of transduced T cells for administration
|
|
EP2872218A4
(en)
|
2012-07-13 |
2016-07-06 |
Univ Pennsylvania |
COMPOSITIONS AND METHOD FOR REGULATING HAIR GROWTH
|
|
MX2015000438A
(es)
|
2012-07-13 |
2016-04-25 |
Univ Pennsylvania |
Manejo de toxicidad para actividad antitumoral de cars.
|
|
CN102775500A
(zh)
|
2012-08-03 |
2012-11-14 |
郑骏年 |
嵌合抗原受体iRGD-scFv(G250)-CD8-CD28-CD137-CD3ζ及其用途
|
|
SMT202100005T1
(it)
|
2012-08-20 |
2021-05-07 |
Hutchinson Fred Cancer Res |
Metodo e composizioni per immunoterapia cellulare
|
|
US9409992B2
(en)
|
2012-08-21 |
2016-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
|
AU2013312838B2
(en)
|
2012-09-04 |
2018-11-29 |
Cellectis |
Multi-chain chimeric antigen receptor and uses thereof
|
|
US9879065B2
(en)
|
2012-09-14 |
2018-01-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors recognizing MHC class II-restricted MAGE-A3
|
|
JP6307085B2
(ja)
|
2012-09-27 |
2018-04-04 |
ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズThe United States of America,as represented by the Secretary,Department of Health and Human Services |
メソテリン抗体および強力な抗腫瘍活性を惹起するための方法
|
|
AR092745A1
(es)
|
2012-10-01 |
2015-04-29 |
Univ Pennsylvania |
Composiciones que comprenden un dominio de union anti-fap y metodos para hacer blanco en celulas estromales para el tratamiento del cancer
|
|
EP2903637B1
(en)
|
2012-10-02 |
2019-06-12 |
Memorial Sloan-Kettering Cancer Center |
Compositions and methods for immunotherapy
|
|
WO2014055771A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
|
US10117896B2
(en)
|
2012-10-05 |
2018-11-06 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
|
CA2886684C
(en)
|
2012-10-10 |
2023-09-19 |
Sangamo Biosciences, Inc. |
T cell modifying compounds and uses thereof
|
|
WO2014059248A1
(en)
|
2012-10-12 |
2014-04-17 |
Philadelphia Health & Education Corporation D/B/A/ Drexel |
Mir-155 enhancement of cd8+ t cell immunity
|
|
UY35103A
(es)
|
2012-10-29 |
2014-05-30 |
Glaxo Group Ltd |
Compuestos de cefem 2-sustituidos
|
|
WO2014099671A1
(en)
|
2012-12-20 |
2014-06-26 |
Bluebird Bio, Inc. |
Chimeric antigen receptors and immune cells targeting b cell malignancies
|
|
ES2776698T3
(es)
|
2012-12-20 |
2020-07-31 |
Purdue Research Foundation |
Células T que expresan un receptor antigénico quimérico como terapia contra el cáncer
|
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
KR102417657B1
(ko)
|
2013-02-06 |
2022-07-07 |
안트로제네시스 코포레이션 |
개선된 특이성을 갖는 변경된 t 림프구
|
|
JO3529B1
(ar)
|
2013-02-08 |
2020-07-05 |
Amgen Res Munich Gmbh |
مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد
|
|
PL3300745T3
(pl)
|
2013-02-15 |
2020-03-31 |
The Regents Of The University Of California |
Chimeryczny receptor antygenowy i sposoby jego zastosowania
|
|
ES2760023T3
(es)
|
2013-02-20 |
2020-05-12 |
Univ Pennsylvania |
Tratamiento del cáncer utilizando receptor de antígeno quimérico anti-EGFRvIII humanizado
|
|
EP2958942B1
(en)
|
2013-02-20 |
2020-06-03 |
Novartis AG |
Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
US9402888B2
(en)
|
2013-03-14 |
2016-08-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for treating cancer
|
|
US9499855B2
(en)
|
2013-03-14 |
2016-11-22 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
|
PT2968552T
(pt)
|
2013-03-14 |
2020-05-18 |
Scripps Research Inst |
Anticorpo dos agentes alvo, combinações e uso para os mesmos
|
|
SG11201506974XA
(en)
|
2013-03-14 |
2015-10-29 |
Bellicum Pharmaceuticals Inc |
Methods for controlling t cell proliferation
|
|
US9587237B2
(en)
|
2013-03-14 |
2017-03-07 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
|
US9393268B2
(en)
|
2013-03-15 |
2016-07-19 |
Thomas Jefferson University |
Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
|
|
AU2014240083C1
(en)
|
2013-03-15 |
2019-10-24 |
Celgene Corporation |
Modified T lymphocytes
|
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
|
EP2970426B1
(en)
|
2013-03-15 |
2019-08-28 |
Michael C. Milone |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
|
US9446105B2
(en)
|
2013-03-15 |
2016-09-20 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor specific for folate receptor β
|
|
US9561291B2
(en)
|
2013-03-15 |
2017-02-07 |
Imre Kovesdi |
Methods of targeting T-cells to tumors
|
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
|
WO2014160627A1
(en)
|
2013-03-25 |
2014-10-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 polypeptides, proteins, and chimeric antigen receptors
|
|
US9629877B2
(en)
|
2013-05-14 |
2017-04-25 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (CAR) T-cells
|
|
WO2014186585A2
(en)
|
2013-05-15 |
2014-11-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for treatment of a genetic condition
|
|
SG11201509609SA
(en)
|
2013-05-24 |
2015-12-30 |
Univ Texas |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
|
JP6608807B2
(ja)
|
2013-05-29 |
2019-11-20 |
セレクティス |
Rnaガイドcasヌクレアーゼ系を用いることによって免疫療法のためにt細胞を操作するための方法
|
|
CA2912172A1
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
WO2014200891A1
(en)
|
2013-06-11 |
2014-12-18 |
THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTEMENT OF HEALTH & HUMAN SERVICES |
Her2-specific monoclonal antibodies and conjugates thereof
|
|
ES2782834T3
(es)
|
2013-06-25 |
2020-09-16 |
Vaccinex Inc |
Uso de moléculas inhibidoras de semaforina-4D en combinación con una terapia inmunomoduladora para inhibir el crecimiento tumoral y la metástasis
|
|
CA3173052A1
(en)
|
2013-08-30 |
2015-03-05 |
Board Of Regents, The University Of Texas System |
Administration of kynurenine depleting enzymes for tumor therapy
|
|
US20150073154A1
(en)
|
2013-09-11 |
2015-03-12 |
Equip, Llc |
Discrete PEG Based Dyes
|
|
EP4269421A3
(en)
|
2013-10-11 |
2023-12-27 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Tem8 antibodies and their use
|
|
ES2741308T3
(es)
|
2013-10-15 |
2020-02-10 |
Scripps Research Inst |
Interruptores de células T con receptores de antígenos quiméricos y usos de los mismos
|
|
ES2845924T3
(es)
|
2013-10-15 |
2021-07-28 |
Scripps Research Inst |
Interruptores de células T con receptores de antígenos quiméricos peptídicos y usos de los mismos
|
|
US10144770B2
(en)
|
2013-10-17 |
2018-12-04 |
National University Of Singapore |
Chimeric receptors and uses thereof in immune therapy
|
|
MX389160B
(es)
|
2013-10-31 |
2025-03-20 |
Hutchinson Fred Cancer Res |
Células no t efectoras y madre/progenitoras hematopoyéticas modificadas y usos de estas.
|
|
EP3626748A1
(en)
|
2014-01-13 |
2020-03-25 |
Stephen J. Forman |
Chimeric antigen receptors (cars) having mutations in the fc spacer region and methods for their use
|
|
EP3094354B1
(en)
|
2014-01-14 |
2018-10-17 |
Cellectis |
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish
|
|
US9694033B2
(en)
|
2014-01-24 |
2017-07-04 |
The Cleveland Clinic Foundation |
IL-9 secreting CD8+ Tc9 cells and methods of treating cancer
|
|
EP3542816A1
(en)
|
2014-02-14 |
2019-09-25 |
Immune Design Corp. |
Immunotherapy of cancer through combination of local and systemic immune stimulation
|
|
CN106132423B
(zh)
|
2014-02-14 |
2020-07-31 |
贝里坤制药股份有限公司 |
用诱导型嵌合多肽活化t细胞的方法
|
|
ES2978993T3
(es)
|
2014-02-21 |
2024-09-23 |
Ibc Pharmaceuticals Inc |
Terapia de enfermedades mediante la inducción de la respuesta inmunitaria a las células que expresan Trop-2
|
|
CN106471004A
(zh)
|
2014-02-28 |
2017-03-01 |
麦吉尔大学学术发展皇家学院 |
作为用于免疫疗法的apc活化剂的tc‑ptp抑制剂
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
KR101605421B1
(ko)
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
|
CA2940460A1
(en)
|
2014-03-07 |
2015-09-11 |
Bellicum Pharmaceuticals, Inc. |
Caspase polypeptides having modified activity and uses thereof
|
|
WO2015142661A1
(en)
|
2014-03-15 |
2015-09-24 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
JP2017513818A
(ja)
|
2014-03-15 |
2017-06-01 |
ノバルティス アーゲー |
キメラ抗原受容体を使用する癌の処置
|
|
ES2876263T3
(es)
|
2014-04-07 |
2021-11-12 |
Novartis Ag |
Tratamiento del cáncer usando receptor de antígeno quimérico anti-cd19
|
|
WO2015157299A2
(en)
|
2014-04-09 |
2015-10-15 |
Seattle Children's Hospital (Dba Seattle Children's Research Institute |
Inhibition of lactate dehydrogenase 5 (ldh-5) binding, incorporation, internalization and/or endocytosis to immune cells
|
|
NZ739448A
(en)
|
2014-04-10 |
2019-10-25 |
Seattle Children’S Hospital Dba Seattle Children’S Res Institute |
Transgene genetic tags and methods of use
|
|
WO2015164594A1
(en)
|
2014-04-23 |
2015-10-29 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) for use in therapy and methods for making the same
|
|
US10494422B2
(en)
|
2014-04-29 |
2019-12-03 |
Seattle Children's Hospital |
CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
|
|
US20170210818A1
(en)
|
2014-06-06 |
2017-07-27 |
The California Institute For Biomedical Research |
Constant region antibody fusion proteins and compositions thereof
|
|
WO2015191874A1
(en)
|
2014-06-12 |
2015-12-17 |
Children's National Medical Center |
Generation of broadly-specific, virus-immune cells targeting multiple hiv antigens for preventive and therapeutic use
|
|
SG11201700416TA
(en)
|
2014-07-21 |
2017-02-27 |
Novartis Ag |
Treatment of cancer using a cd33 chimeric antigen receptor
|
|
US10174095B2
(en)
|
2014-07-21 |
2019-01-08 |
Novartis Ag |
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
|
|
EP3171882A1
(en)
|
2014-07-21 |
2017-05-31 |
Novartis AG |
Treatment of cancer using a cll-1 chimeric antigen receptor
|
|
PL3177640T3
(pl)
|
2014-08-08 |
2020-11-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Charakteryzujące się wysokim powinowactwem środki terapeutyczne naśladujące PD-11 i sposoby ich wykorzystania
|
|
US11141494B2
(en)
|
2014-08-09 |
2021-10-12 |
Purdue Research Foundation |
Development of neurokinin-1 receptor-binding agent delivery conjugates
|
|
NZ729046A
(en)
|
2014-08-12 |
2022-07-29 |
Celgene Corp |
Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tract
|
|
DK3183268T3
(da)
|
2014-08-19 |
2020-05-11 |
Univ Pennsylvania |
Behandling af cancer ved anvendelse af en cd123-kimær antigenreceptor
|
|
EP3189148A4
(en)
|
2014-09-02 |
2018-05-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
CN107002084B
(zh)
|
2014-09-19 |
2021-09-10 |
希望之城公司 |
靶向IL13Rα2的共刺激嵌合抗原受体T细胞
|
|
WO2016054520A2
(en)
|
2014-10-03 |
2016-04-07 |
The California Institute For Biomedical Research |
Engineered cell surface proteins and uses thereof
|
|
US9943612B2
(en)
|
2014-10-09 |
2018-04-17 |
Seattle Children's Hospital |
Long poly(A) plasmids and methods for introduction of long poly(A) sequences into the plasmid
|
|
AU2015333728B2
(en)
|
2014-10-14 |
2020-07-30 |
Riptide Bioscience, Inc. |
Peptide-based methods for treating pancreatic cancer
|
|
AU2015338893A1
(en)
|
2014-10-31 |
2017-05-04 |
Massachusetts Institute Of Technology |
Delivery of biomolecules to immune cells
|
|
AU2015343013B2
(en)
|
2014-11-05 |
2020-07-16 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CN113897285A
(zh)
|
2014-11-14 |
2022-01-07 |
麻省理工学院 |
化合物和组合物向细胞中的破坏和场实现的递送
|
|
KR102500181B1
(ko)
|
2014-11-17 |
2023-02-14 |
셀렉타 바이오사이언시스, 인코퍼레이티드 |
암-표적화 약물 운송수단으로서의 인지질 에테르 유사체
|
|
SG11201704519YA
(en)
|
2014-12-02 |
2017-07-28 |
Roger Williams Hospital |
Methods and compositons for treating cancer
|
|
JP7098325B2
(ja)
|
2014-12-05 |
2022-07-11 |
シティ・オブ・ホープ |
Cs1標的化キメラ抗原レセプター改変t細胞
|
|
EP4400516A1
(en)
|
2014-12-15 |
2024-07-17 |
The Regents of the University of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
CA2966241A1
(en)
|
2014-12-15 |
2016-06-23 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
|
HK1245829A1
(zh)
|
2014-12-15 |
2018-08-31 |
Bellicum Pharmaceuticals, Inc. |
受控消除治疗性细胞的方法
|
|
WO2016098078A2
(en)
|
2014-12-19 |
2016-06-23 |
Novartis Ag |
Dimerization switches and uses thereof
|
|
KR102376244B1
(ko)
|
2014-12-24 |
2022-03-21 |
오토러스 리미티드 |
세포
|
|
RU2751362C2
(ru)
|
2014-12-29 |
2021-07-13 |
Новартис Аг |
Способы получения экспрессирующих химерный антигенный рецептор клеток
|
|
JP6797803B2
(ja)
|
2014-12-31 |
2020-12-09 |
セルジーン コーポレイション |
ナチュラルキラー細胞を用いて血液障害、固形腫瘍、又は感染性疾患を治療する方法
|
|
US9765330B1
(en)
|
2015-01-09 |
2017-09-19 |
Nant Holdings Ip, Llc |
Compositions and methods for reduction of allograft recognition and rejection
|
|
JP6858128B2
(ja)
|
2015-02-18 |
2021-04-14 |
エンリヴェックス セラピューティクス リミテッド |
癌治療のための免疫療法とサイトカイン制御療法との組み合わせ
|
|
AU2016222887B2
(en)
|
2015-02-24 |
2022-07-14 |
The Regents Of The University Of California |
Binding-triggered transcriptional switches and methods of use thereof
|
|
RU2688692C2
(ru)
|
2015-03-02 |
2019-05-22 |
Инновейтив Целлюлар Терапевтикс КО., ЛТД. |
Фармацевтическая композиция, обладающая противоопухолевым эффектом, и способ снижения ингибирующего эффекта pd-l1 на т-клетки человека
|
|
WO2016149254A1
(en)
|
2015-03-17 |
2016-09-22 |
Chimera Bioengineering, Inc. |
Smart car devices, de car polypeptides, side cars and uses thereof
|
|
US20180079824A1
(en)
|
2015-03-18 |
2018-03-22 |
Baylor College Of Medicine |
HER2/ErbB2 Chimeric Antigen Receptor
|
|
US9717745B2
(en)
|
2015-03-19 |
2017-08-01 |
Zhejiang DTRM Biopharma Co. Ltd. |
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
|
|
WO2016154628A1
(en)
|
2015-03-26 |
2016-09-29 |
Xiuli Wang |
Bi-specific targeted chimeric antigen receptor t cells
|
|
WO2016154621A1
(en)
|
2015-03-26 |
2016-09-29 |
The California Institute For Biomedical Research |
SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
EP3283113A4
(en)
|
2015-04-15 |
2018-12-05 |
The California Institute for Biomedical Research |
Optimized pne-based chimeric receptor t cell switches and uses thereof
|
|
WO2016168769A1
(en)
|
2015-04-15 |
2016-10-20 |
The California Institute For Biomedical Research |
Chimeric receptor t cell switches for her2
|
|
WO2016187158A1
(en)
|
2015-05-15 |
2016-11-24 |
City Of Hope |
Chimeric antigen receptor compositions
|
|
WO2016187407A1
(en)
|
2015-05-19 |
2016-11-24 |
Morphogenesis, Inc. |
Cancer vaccine comprising mrna encoding a m-like-protein
|
|
JP7197979B2
(ja)
|
2015-05-28 |
2022-12-28 |
カイト ファーマ インコーポレイテッド |
T細胞療法のために患者をコンディショニングする方法
|
|
CA2983456A1
(en)
|
2015-06-12 |
2016-12-15 |
Immunomedics, Inc. |
Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs
|
|
US9663756B1
(en)
|
2016-02-25 |
2017-05-30 |
Flodesign Sonics, Inc. |
Acoustic separation of cellular supporting materials from cultured cells
|
|
JP2018518972A
(ja)
|
2015-06-26 |
2018-07-19 |
ユニバーシティ オブ サザン カリフォルニア |
腫瘍特異的活性化のためのマスキングキメラ抗原受容体t細胞
|
|
GB201514328D0
(en)
|
2015-08-12 |
2015-09-23 |
Sigmoid Pharma Ltd |
Compositions
|
|
GB201514875D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Receptor
|
|
GB201514874D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Cell
|
|
WO2017035362A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Use of complement pathway inhibitor compounds to mitigate adoptive t-cell therapy associated adverse immune responses
|
|
EP3347026A4
(en)
|
2015-09-09 |
2019-05-08 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
GENEMANIPULATION OF MACROPHAGES FOR IMMUNOTHERAPY
|
|
US9790467B2
(en)
|
2015-09-22 |
2017-10-17 |
Qt Holdings Corp |
Methods and compositions for activation or expansion of T lymphocytes
|
|
KR20250013291A
(ko)
|
2015-10-05 |
2025-01-31 |
프리시젼 바이오사이언시스 인코포레이티드 |
변형된 인간 t 세포 수용체 알파 불변 영역 유전자를 포함하는 유전자 변형된 세포
|
|
IL299114A
(en)
|
2015-10-06 |
2023-02-01 |
Hope City |
Chimeric antigen receptors targeting PSCA
|
|
GB201518817D0
(en)
|
2015-10-23 |
2015-12-09 |
Autolus Ltd |
Cell
|
|
GB201518816D0
(en)
|
2015-10-23 |
2015-12-09 |
Autolus Ltd |
Receptor
|
|
CA3004299A1
(en)
|
2015-11-05 |
2017-05-11 |
City Of Hope |
Methods for preparing cells for adoptive t cell therapy
|
|
EP3373938A4
(en)
|
2015-11-09 |
2019-05-15 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
NOVEL RNA-BASED VECTOR SYSTEM FOR TEMPORARY AND STABLE GENE EXPRESSION
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Cxcr2抑制劑
|
|
SG11201804694SA
(en)
|
2015-12-14 |
2018-07-30 |
Bellicum Pharmaceuticals Inc |
Dual controls for therapeutic cell activation or elimination
|
|
US9849092B2
(en)
|
2015-12-21 |
2017-12-26 |
Gholam A. Peyman |
Early cancer detection and enhanced immunotherapy
|
|
EP4219689A3
(en)
|
2015-12-30 |
2023-12-20 |
Novartis AG |
Immune effector cell therapies with enhanced efficacy
|
|
SG10201913805RA
(en)
|
2016-01-08 |
2020-03-30 |
Univ California |
Conditionally active heterodimeric polypeptides and methods of use thereof
|
|
SG11201805792PA
(en)
|
2016-01-11 |
2018-08-30 |
Univ Leland Stanford Junior |
Chimeric proteins and methods of regulating gene expression
|
|
EP3402509A4
(en)
|
2016-01-14 |
2019-07-10 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
TUMOR SPECIFIC IFNA SECRETION BY CAR T CELLS FOR RESTORING SOLID TUMOR MICRO ENVIRONMENT
|
|
EP3411393B1
(en)
|
2016-02-05 |
2021-04-07 |
City of Hope |
Administration of engineered t cells for treatment of cancers in the central nervous system
|
|
GB201602571D0
(en)
|
2016-02-12 |
2016-03-30 |
Autolus Ltd |
Signalling system
|
|
GB201602563D0
(en)
|
2016-02-12 |
2016-03-30 |
Autolus Ltd |
Signalling system
|
|
JP2019508036A
(ja)
|
2016-02-16 |
2019-03-28 |
ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド |
免疫療法組成物及び方法
|
|
EP3416690A4
(en)
|
2016-02-19 |
2020-02-19 |
City of Hope |
BISPECIFIC APTAMER
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
IL261713B2
(en)
|
2016-03-19 |
2023-09-01 |
F1 Oncology Inc |
Methods and preparations for the transfer of lymphocytes and their regulated expansion
|
|
MX2018011480A
(es)
|
2016-03-22 |
2019-03-28 |
Seattle Children´S Hospital Dba Seattle Children´S Res Institute |
Metodos de intervencion temprana para prevenir o aminorar toxicidad.
|
|
JP7282521B2
(ja)
|
2016-04-08 |
2023-05-29 |
パーデュー・リサーチ・ファウンデイション |
Car t細胞療法のための方法および組成物
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
US11136405B2
(en)
|
2016-06-06 |
2021-10-05 |
Board Of Regents, The Unviersity Of Texas System |
BAFF-R antibodies and uses thereof
|
|
CN109311991B
(zh)
|
2016-06-06 |
2022-08-30 |
希望之城 |
Baff-r靶向嵌合抗原受体修饰的t细胞及其用途
|
|
GB201610515D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Cell
|
|
GB201610512D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Chimeric antigen receptor
|
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
|
ES3032115T3
(en)
|
2016-07-13 |
2025-07-15 |
Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
CN110199018B
(zh)
|
2016-08-09 |
2024-06-07 |
希望之城 |
嵌合痘病毒组合物及其用途
|
|
US9642906B2
(en)
|
2016-09-16 |
2017-05-09 |
Baylor College Of Medicine |
Generation of HPV-specific T-cells
|
|
US11116834B2
(en)
|
2016-10-19 |
2021-09-14 |
City Of Hope |
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
|
|
WO2018075794A1
(en)
|
2016-10-19 |
2018-04-26 |
City Of Hope |
Use of triplex cmv vaccine in car t cell therapy
|
|
AU2017345479B2
(en)
|
2016-10-19 |
2024-03-21 |
The Scripps Research Institute |
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
|
|
US10617720B2
(en)
|
2016-10-20 |
2020-04-14 |
Miltenyi Biotech, GmbH |
Chimeric antigen receptor specific for tumor cells
|
|
EP3532105B1
(en)
|
2016-10-31 |
2025-07-09 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogennous foxp3 gene
|
|
WO2018102761A1
(en)
|
2016-12-02 |
2018-06-07 |
City Of Hope |
Methods for manufacturing and expanding t cells expressing chimeric antigen receptors and other receptors
|
|
CN110291200B
(zh)
|
2016-12-12 |
2024-05-14 |
西雅图儿童医院(Dba西雅图儿童研究所) |
对哺乳动物细胞中转基因表达的药剂配体诱导具有增大的灵敏度的嵌合转录因子变异体
|
|
US11753460B2
(en)
|
2016-12-13 |
2023-09-12 |
Seattle Children's Hospital |
Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo
|
|
EP3336107A1
(en)
|
2016-12-15 |
2018-06-20 |
Miltenyi Biotec GmbH |
Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
|
|
CN110381989A
(zh)
|
2016-12-21 |
2019-10-25 |
丹麦技术大学 |
用于免疫细胞操作的抗原呈递支架
|
|
US11649288B2
(en)
|
2017-02-07 |
2023-05-16 |
Seattle Children's Hospital |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
JP7288402B2
(ja)
|
2017-02-17 |
2023-06-07 |
パーデュー・リサーチ・ファウンデーション |
細胞医療用の標的リガンド-ペイロードによる薬剤デリバリー
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
US20200405881A1
(en)
|
2017-03-06 |
2020-12-31 |
University Of Washington |
Cell based methods and compositions for therapeutic agent delivery and treatments using same
|
|
US20200276318A1
(en)
|
2017-03-06 |
2020-09-03 |
University Of Washington |
Engineered cells and agent compositions for therapeutic agent delivery and treatments using same
|
|
WO2018170150A2
(en)
|
2017-03-16 |
2018-09-20 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins
|
|
JP2020511498A
(ja)
|
2017-03-20 |
2020-04-16 |
シティ・オブ・ホープCity of Hope |
Alアミロイドーシスの治療のためのcs1標的化キメラ抗原レセプター改変t細胞
|
|
WO2018213332A1
(en)
|
2017-05-17 |
2018-11-22 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Generating mammalian t cell activation inducible synthetic promoters (syn+pro) to improve t cell therapy
|
|
KR20200038490A
(ko)
|
2017-08-01 |
2020-04-13 |
시티 오브 호프 |
항-il1rap 항체
|
|
US20200181264A1
(en)
|
2017-08-11 |
2020-06-11 |
City Of Hope |
Bispecific antigen-binding molecule
|
|
CN112292138A
(zh)
|
2018-01-22 |
2021-01-29 |
西雅图儿童医院(Dba西雅图儿童研究所) |
Car t细胞的使用方法
|
|
SG11202007426XA
(en)
|
2018-02-06 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
WO2019165237A1
(en)
|
2018-02-23 |
2019-08-29 |
Endocyte, Inc. |
Sequencing method for car t cell therapy
|
|
US12215337B2
(en)
|
2018-04-12 |
2025-02-04 |
Umoja Biopharma, Inc. |
Viral vectors and packaging cell lines
|
|
EP3784259A4
(en)
|
2018-04-27 |
2021-12-29 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Rapamycin resistant cells
|
|
KR20210074274A
(ko)
|
2018-08-06 |
2021-06-21 |
시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 |
합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물
|
|
CA3108710A1
(en)
|
2018-08-07 |
2020-02-13 |
Purdue Research Foundation |
Rejuvenation of car t cell
|
|
WO2020106992A1
(en)
|
2018-11-21 |
2020-05-28 |
Umoja Biopharma, Inc. |
Multicistronic vector for surface engineering lentiviral particles
|
|
EP3993814A4
(en)
|
2019-07-05 |
2023-06-28 |
Purdue Research Foundation |
Design and efficient synthesis of lipid-fluorescein conjugates for car-t cell therapy
|
|
MX2022003215A
(es)
|
2019-09-17 |
2022-04-25 |
Purdue Research Foundation |
Formacion de imagenes especificas para proteina de activacion de fibroblastos (fap) y terapia contra tipos de cancer y otras enfermedades fibroticas e inflamatorias.
|
|
CA3154281A1
(en)
|
2019-10-16 |
2021-04-22 |
Andrew Scharenberg |
Retroviral vector for universal receptor therapy
|
|
IL295129A
(en)
|
2020-01-30 |
2022-09-01 |
Umoja Biopharma Inc |
Bispecific transduction enhancer
|
|
CN115397440A
(zh)
|
2020-02-04 |
2022-11-25 |
西雅图儿童医院(Dba西雅图儿童研究所) |
用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物
|
|
CN115210252A
(zh)
|
2020-02-04 |
2022-10-18 |
西雅图儿童医院(Dba西雅图儿童研究所) |
抗二硝基苯酚的嵌合抗原受体
|
|
IL296176A
(en)
|
2020-03-06 |
2022-11-01 |
Purdue Research Foundation |
Methods, compounds and compositions for altering car-t cell activity
|
|
WO2022015955A1
(en)
|
2020-07-16 |
2022-01-20 |
Umoja Biopharma, Inc. |
Gated adapter targeting receptor
|
|
US20230407330A1
(en)
|
2020-11-20 |
2023-12-21 |
Umoja Biopharma, Inc. |
Vector system for delivery of multiple polynucleotides and uses thereof
|
|
WO2022164935A1
(en)
|
2021-01-27 |
2022-08-04 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|
|
IL317466A
(en)
|
2022-06-09 |
2025-02-01 |
Umoja Biopharma Inc |
Compounds and methods for NK cell differentiation
|